We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App





Beckman Coulter's New Solutions Demonstrated at 2013 AACC Annual Meeting

By LabMedica International staff writers
Posted on 01 Aug 2013
Print article
Beckman Coulter (Brea, CA, USA) demonstrated its dedication to advancing and optimizing the lab at the 2013 American Association of Clinical Chemistry (AACC) and Clinical Lab Expo in Houston (TX, USA) from July 30–August 1, 2013.

The Beckman Coulter exhibition booth showcased the company’s latest products in total lab automation, scalable solutions, and small footprint systems, including the new Power Express automation solution which streamlines lab workflow and increases flexibility to ultimately decrease turnaround time. The Power Link, also demonstrated, offers labs the ability to combine an AU680 chemistry analyzer with a DxI immunoassay analyzer to form an entry level automated workcell.

Moreover, the latest addition of the IRIS Diagnostics (Chatsworth, CA, USA) urinalysis portfolio and presentations on the company’s newest troponin I assay, AccuTnI+3 on the Access 2 immunoassay system was demonstrated.

Attendees were given opportunities to view Beckman Coulter's newest cellular analysis systems, high-throughput chemistry analyzers, and clinical information solutions in a unique booth design that exhibits the company’s lab automation for the core, reference, and community hospital lab.

Visitors to Beckman Coulter’s booth have the opportunity to learn from industry experts how the company’s latest diagnostic innovations advance and optimize patient care and hear examples of how Beckman Coulter moves the lab forward by increasing efficiency, productivity, and uptime.

Related Links:
Beckman Coulter
Iris Diagnostics


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
New
Gastrointestinal Infection Test
RIDA QUICK Cryptosporidium/Giardia/Entamoeba Combi Test
New
Anti-Annexin V IgG/IgM Assay
Anti-Annexin V IgG/IgM ELISA

Print article

Channels

Molecular Diagnostics

view channel
Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Microbiology

view channel
Image: The Cytovale System isolates, images, and analyzes cells (Photo courtesy of Cytovale)

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.